DDX6 and neurodegenerative disease: On the other hand, disruption of the P-bodies due to deprival of the soluble DDX6, MARF1 exists in an active state that can degrade the target mRNA, leading to dysregulation of mRNA and translational repression, which is considered as an alternative mechanism for Atx2-associated neurodegenerative diseases.